Table 2.
The proportion of patients with detectable cytokines in the aqueous of patients that had cataract surgery at RHSP, south-western Uganda
| Cytokine | HIV+ | HIV- | p-value | ||
|---|---|---|---|---|---|
| Number | Percentage | Number | Percentage | ||
| IL-6 | 25 | (100%) | 25 | (100%) | – |
| IFN-g | 17 | (68%) | 8 | (32%) | 0.037* |
| GM-CSF | 19 | (86%) | 22 | (92%) | 0.659 |
| TNF-a | 21 | (95%) | 12 | (50%) | 0.001* |
| IL-2 | 15 | (68%) | 5 | (21%) | 0.003* |
| IL-4 | 17 | (77%) | 8 | (33%) | 0.004* |
| IL-8 | 25 | (100%) | 25 | (100%) | – |
| IL-10 | 24 | (96%) | 17 | (68%) | 0.023* |
*Significant difference in proportion of cases with detectable cytokines higher among HIV positive cases compared to HIV negative cases
IL-6 Interleukin 6, IFN-g Interferon –gamma, GM-CSF Granulocyte macrophage colony stimulating factor, TNF-a Tumour necrosis factor alpha, IL-2 Interleukin 2, IL-4 Interleukin 4, IL-8 Interleukin 8, IL-10 Interleukin 10, RHSP Rakai Health Service Programme